← All trends
Confidence: StrongAs of 2026-07-10
global · market pattern
Obesity market: 5.8M searches a month
About 5.8M people a month search Obesity across 30 tracked markets. The products this group turns to are led by Mounjaro, Glp 1, Tirzepatide.
What the Obesity economy actually looks like, sized by real search demand and the products people turn to.
What it isthe chronic metabolic condition of excess body fat
Working hypothesisAI-suggested
The obesity market is now GLP-1 first, Mounjaro and the tirzepatide family own most of the searchable demand.
The evidence
- condition demand
- 5.8M searches a month for Obesity itself, summed across 30 tracked markets (2026-06) [MEASURED]
- top linked demand
- Mounjaro: 7.8M searches a month [MEASURED]
- map
- 12 products mapped to Obesity in the demand-driver map [MEASURED edges, INFERRED that this population searches and buys them]
- note
- Headline is search demand for the condition term itself, a clean measured number. Linked products are ranked by their own global demand; they overlap across conditions (a GLP-1 search is not only a PCOS search), so they are shown as a leaderboard, not summed into a single market size. Money and sales are not measured.
The full ranking
6 tracked · obesity demand-driver map.
- 1Mounjaro7.8M/mo
- 2Glp 13.9M/mo, +10% 6mo
- 3Tirzepatide3.2M/mo, +28% 6mo
- 4Wegovy3M/mo, +9% 6mo
- 5Semaglutide2.1M/mo
- 6Zepbound1.1M/mo, +6% 6mo